Rare metabolic diseases among the Irish travellers: results from the All Ireland Traveller Health Study census and birth cohort (2007-2011)

Noor Aman Hamid, Cecily Kelleher, Catherine McGorrian, Leslie Daly, Patricia Fitzpatrick

Abstract


Irish Travellers are a minority population group on the island of Ireland, in whom it has been documented previously that some rare inborn metabolic diseases are more prevalent. However, these were mostly based on population estimates, rather than accurate denominator data. This study aimed to document the prevalence of these rare metabolic diseases, employing data from the All Ireland Health Study census and subsequent birth cohort study (2007-2011). The prevalences for Hurler disease, Phenyketonuria, Galactosaemia and Brittle Bone Disease were 1.3, 1.3, 2.6 and 1.9 per 1,000 Traveller children respectively.  Other recorded diseases were Mucolipidosis type II, Marfan’s syndrome, Charcot-Marie-Tooth, Phenyketonuria and Byler’s Disease. These, however, may be an under-estimated numbers and also highlights the limitations in rare diseases epidemiology. There is a limited newborn screening service in the Republic of Ireland; given the higher prevalence of these metabolic diseases among the Travellers, a Traveller-specific prevention strategy should be considered. Services should also be sensitive to the needs of the population.

Keywords


rare diseases epidemiology, metabolic diseases, Irish travellers

Full Text:

PDF

References


Jinnah HA. Needles in haystacks: the challenges of rare diseases. Developmental Medicine and Child Neurology. 2011 Jan;53(1):6-7.

Day S. Evidence-Based Medicine and Rare Diseases. Rare Diseases Epidemiology 2010:41-53.

Schieppati A, Henter JI, Daina E, Aperia A. Why rare diseases are an important medical and social issue. The Lancet 2008;371(9629):2039-41.

Pampols T. Inherited Metabolic Rare Disease. Rare Diseases Epidemiology 2010;686(5):397-431.

Groft SC, Paz MP. Rare Diseases–Avoiding Misperceptions and Establishing Realities: The Need for Reliable Epidemiological Data. Rare Diseases Epidemiology 2010:3-14.

RD-Connect (EU). About RD-Connect. 2014 [updated 2014; cited 20 January 2014] Available from: http://rd-connect.eu/ about

National Institutes of Health (US). Global Rare Disease Patient Registry And Data Repository. 2014 [Updated 2014; cited 20 January 2014] Available from: http://rarediseases.info.nih.gov/research/pages/43/global-rare-disease-patient-registry-and-data-repository

Equality Authority. Traveller ethnicity: an Equality Authority Report. Dublin: Brunswick Press Ltd, 2006.

All Ireland Traveller Health Study Team. Technical Report 1: Health Survey Findings. In: Kelleher C, editor. All Ireland Traveller Health Study. Dublin: Department of Health and Children, 2010.

Hamid N, Daly L, Fitzpatrick P. Technical Report 2D: The Birth Cohort Follow Up. In: Kelleher C, editor. All Ireland Traveller Health Study. Dublin: University College Dublin, 2011.

Paz MP, Villaverde-Hueso A, Alonso V, János S, Zurriaga Ó, Pollán M, et al. Rare Diseases Epidemiology Research. Rare Diseases Epidemiology 2010:17-39.

Murphy AM, Lambert D, Treacy EP, O'Meara A, Lynch SA. Incidence and prevalence of mucopolysaccharidosis type 1 in the Irish republic. Archives of Disease in Childhood. 2009;94(1):52-4.

Murphy M, McHugh B, Tighe O, Mayne P, O'Neill C, Naughten E, et al. Genetic basis of transferase-deficient galactosaemia in ireland and the population history of the irish travellers. European Journal of Human Genetics. 1999;7(5):549-54.

Barry J, Daly L. The Travellers' Health Status Study: Census of Travelling People, November 1986. Dublin: The Health Research Board, 1988.

Coss KP, Doran PP, Owoeye C, Codd MB, Hamid N, Mayne PD, et al. Classical Galactosaemia in Ireland: incidence, complications and outcomes of treatment. Journal of Inherited Metabolic Disease. 2013;36(1):21-7.

Hamid N, Turner J, Abdalla S, Quirke B, Daly L, Fitzpatrick P. Technical Report 2B: The Birth Cohort Study. In: Kelleher C, editor. All Ireland Traveller Health Study. Dublin: Department of Health and Children, 2010.

Orphanet. Prevalence of rare diseases: Bibliographic data. Orphanet Report Series. France, 2012.

Moore D, Connock MJ, Wraith E, Lavery C. The prevalence of and survival in Mucopolysaccharidosis I: Hurler, Hurler-Scheie and Scheie syndromes in the UK. Orphanet Journal of Rare Diseases. 2008;3.

Murphy AM, Lambert D, Treacy EP, O'Meara A, Lynch SA. Incidence and prevalence of mucopolysaccharidosis type 1 in the Irish republic. Archives of Disease in Childhood. 2009;94(1):52-4

Malm G, Lund AM, Månsson JE, Heiberg A. Mucopolysaccharidoses in the Scandinavian countries: incidence and prevalence. Acta Pædiatrica 2008;97(11):1577-81.

Badawi N, Cahalane SF, McDonald M, Mulhair P, Begi B, Odonohue A, et al. Galactosaemia - A controversial disorder. Screening & outcome. Ireland 1972-1992. Irish Medical Journal. 1996;89(1):16-7.

Barry J, Herity B, Solan J. The Travellers' Health Status Study: Vital Statistics of Travelling People 1987. Dublin: The Health Research Board, 1989.

Orioli I, Castilla E, Barbosa-Neto J. The birth prevalence rates for the skeletal dysplasias. Journal of Medical Genetics. 1986;23(4):328.

Andersen PE, Hauge M. Osteogenesis imperfecta: a genetic, radiological, and epidemiological study. Clinical Genetics. 1989;36(4):250-5.

Martin E, Shapiro JR. Osteogenesis imperfecta: epidemiology and pathophysiology. Current Osteoporosis Reports 2007;5(3):91-97.

McElligot F, Beatty E, O'Sullivan S, Hughes J, Lambert D, Cooper A, et al. Incidence of I-Cell disease (mucolipidosis type II) in the Irish population. Journal of Inherited Metabolic Disease. 2011;34(suppl 3):S206.

Coutinho M, Encarnacao M, Gomes R, Da Silva Santos L, Martins S, Sirois-Gagnon D, et al. Origin and spread of a common deletion causing mucolipidosis type II: insights from patterns of haplotypic diversity. Clinical Genetics 2011;(80):273-280.

Barry J, Kirke P. Congenital anomalies in the Irish traveller community. Irish Medical Journal. 1997;90(6):233-4.

Drummond A. Irish Travellers and the Criminal Justics Systems across the Island of Ireland. University of Ulster, 2010.

McDonagh M. Nomadism in Irish Travellers’ Identity. In: McCann M, O Siochain S, Ruane J, editors. Irish Travellers: Culture and ethnicity. Belfast: Institute of Irish Studies, 1994:30-66.

Jones S. In the blood: Gods, genes and destiny. Hammersmith: Flamingo, 1997.

Bittles AH. THE ROLE AND SIGNIFICANCE OF CONSANGUINITY AS A DEMOGRAPHIC VARIABLE. Population and Development Review. 1994;20(3):561-84.

Al-Gazali L, Hamamy H, Al-Arrayad S. Genetic disorders in the Arab world. BMJ 2006;333(7573):831-34.

Darr A. Access to Genetic Services by Minority Ethnic Populations. A Pilot 1999.

Zlotogora J, Carmi R, Lev B, Shalev SA. A targeted population carrier screening program for severe and frequent genetic diseases in Israel. European. Journal of Human Genetics. 2008;17(5):591-97.

Rosner G, Rosner S, Orr-Urtreger A. Genetic testing in Israel: an overview. Annual Review of Genomics and Human Genetics 2009;10:175-92.

McGorrian C, Shortt E, Doyle O, Kelleher C. Breastfeeding is natural, but it’s not the norm in Ireland, Dublin: Department of Health and Children, 2010.

National Newborn Screening Programme Working Group. Review of the national Screening Programme for Inherited Metabolic Disorders. Dublin: Health Service Executive, 2004.